Chronic central nervous system involvement in Lyme borreliosis (Abstract)

Chronic central nervous system involvement in Lyme borreliosis Neurology June 1988 https://pubmed.ncbi.nlm.nih.gov/3368066/ We describe four patients with marked chronic meningoencephalomyelitis caused by tick-transmitted Borrelia burgdorferi infection. Imaging techniques showed either MS-like lesions or evidence of vascular involvement, as in other spirochetal infections, especially in meningovascular syphilis.

Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation (Abstract)

Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation Sci Rep 6 April 2017 https://pubmed.ncbi.nlm.nih.gov/28386103/ Cytomegalovirus (CMV) is a latent virus which causes chronic activation of the immune system. Here, we demonstrate that cytotoxic and pro-inflammatory CD4+CD28null T cells are only present in CMV seropositive donors and that CMV-specific Immunoglobulin (Ig) G titers correlate with the percentage of […]

Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology… (Abstract)

Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis J Neurosci Res 25 November 2021 https://pubmed.ncbi.nlm.nih.gov/34821408/ Multiple sclerosis (MS) is a progressive disease of the central nervous system (CNS) that primarily affects women during the second or third decade of life. The mechanism […]

Scientists Think They’ve Figured Out What’s Triggering Brain Fog in COVID-19 Patients (News)

Scientists Think They’ve Figured Out What’s Triggering Brain Fog in COVID-19 Patients MSN News Science Alert 11 February 2021 https://www.msn.com/en-us/news/technology/scientists-think-theyve-figured-out-whats-triggering-brain-fog-in-covid-19-patients/ar-BB1dBTTF?li=BBnbfcL Doctors all around the world have noticed a host of lingering effects persisting in patients, long after they appeared to have otherwise recovered from COVID-19. These unusual neurological symptoms – encompassing fatigue, memory loss, confusion, […]

Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients (Abstract)

Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients Cancer Cell 16 January 2021 https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9 SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction that emerges weeks after the acute respiratory infection. To better understand this pathology, we prospectively analyzed of a cohort of cancer patients with neurologic manifestations of COVID-19, including a targeted […]

Low Dose Naltrexone Treatment of Established Relapsing-Remitting Experimental Autoimmune Encephalomyelitis (Abstract)

Low Dose Naltrexone Treatment of Established Relapsing-Remitting Experimental Autoimmune Encephalomyelitis J Multiple Sclerosis January 2015 https://www.researchgate.net/publication/281496691_Low_Dose_Naltrexone_Treatment_of_Established_Relapsing-Remitting_Experimental_Autoimmune_Encephalomyelitis Background: Relapse-remitting multiple sclerosis is a chronic disorder that affects more than 400,000 individuals in the United States, often reducing their quality of life, increasing medical expenses, and limiting mobility. This study examines modulation of the opioid growth factor […]

Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone (Abstract)

Featured Article: Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone Exp Biol Med (Maywood) September 2017 https://pubmed.ncbi.nlm.nih.gov/28766982/ Low-dose naltrexone is a widely used off-label therapeutic prescribed for a variety of immune-related disorders. The mechanism underlying low-dose naltrexone’s efficacy for fatigue, Crohn’s disease, fibromyalgia, and multiple sclerosis is, in part, […]